Hyperlipidemia Clinical Trials

26 recruiting

Hyperlipidemia Trials at a Glance

43 actively recruiting trials for hyperlipidemia are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 20 trials, with the heaviest enrollment activity in Beijing, Indianapolis, and Birmingham. Lead sponsors running hyperlipidemia studies include China National Center for Cardiovascular Diseases, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, and Arrowhead Pharmaceuticals.

Browse hyperlipidemia trials by phase

Treatments under study

About Hyperlipidemia Clinical Trials

Looking for clinical trials for Hyperlipidemia? There are currently 26 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperlipidemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperlipidemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 43 trials

Recruiting
Phase 3

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

Hyperlipidemia
Merck Sharp & Dohme LLC975 enrolled89 locationsNCT07216482
Recruiting
Phase 1

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

HypercholesterolemiaHypertriglyceridemiaRefractory Hyperlipidemia
Verve Therapeutics, Inc.36 enrolled10 locationsNCT06451770
Recruiting
Phase 3

A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.760 enrolled2 locationsNCT07421297
Recruiting
Not Applicable

Mechanism of Ketogenic Diet-Induced Hypercholesterolemia

Hypercholesterolemia and Hyperlipidemia
Washington University School of Medicine100 enrolled1 locationNCT06894004
Recruiting
Not Applicable

Penn Medicine Healthy Heart

HypertensionHyperlipidemias
University of Pennsylvania1,980 enrolled1 locationNCT06062394
Recruiting

Imaging the Pathogenesis of Cerebral Small Vessel Disease

HypertensionDiabetesHyperlipidemias+1 more
Johns Hopkins University50 enrolled1 locationNCT05703386
Recruiting
Not Applicable

Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food

DiabetesPrediabetesHigh Cholesterol/Hyperlipidemia
Cambridge Health Alliance20 enrolled1 locationNCT06988462
Recruiting
Not Applicable

Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)

HypertensionHyperuricemiaHyperglycemia+2 more
China National Center for Cardiovascular Diseases100 enrolled1 locationNCT07400549
Recruiting
Phase 3

A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

Hyperlipidemia
Beijing Suncadia Pharmaceuticals Co., Ltd900 enrolled1 locationNCT07230730
Recruiting
Phase 1

A Study to Evaluate COR-1004 in Adult Volunteers.

Hyperlipidemia
Corsera Health60 enrolled1 locationNCT07229118
Recruiting
Not Applicable

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

Congestive Heart FailureDepressionHypertension+10 more
University of Tennessee388 enrolled2 locationsNCT06374277
Recruiting
Not Applicable

Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease

Hyperlipidemia
Colorado Prevention Center100 enrolled1 locationNCT07334834
Recruiting
Not Applicable

FELLAShip to Better Health

High Blood GlucoseHigh CholesterolHigh Cholesterol/Hyperlipidemia+1 more
University of Alabama at Birmingham90 enrolled1 locationNCT07220213
Recruiting
Phase 1Phase 2

Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

Hyperlipidemia; Mixed
Arrowhead Pharmaceuticals78 enrolled1 locationNCT07223658
Recruiting

Rapid Escalation of LipiD Lowering Therapy to Reduce RecUrrent Cardiovascular Event

HyperlipidemiaCardio Vascular Disease
Chinese University of Hong Kong1,000 enrolled1 locationNCT07311941
Recruiting
Phase 2

A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia

Hyperlipidemia
Shandong Suncadia Medicine Co., Ltd.189 enrolled1 locationNCT07229937
Recruiting
Not Applicable

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients

Diabetes MellitusHypertensionHyperlipidemia+2 more
China National Center for Cardiovascular Diseases536 enrolled1 locationNCT06615609
Recruiting
Phase 2

Zhibitai Capsules for the Treatment of Primary Hyperlipidemia

Primary Hyperlipidemia
Chengdu Diao Jiuhong Pharmaceutical Factory192 enrolled1 locationNCT06822946
Recruiting
Not Applicable

Social Needs Screening and Chronic Diseases Study (WE CARE)

DepressionHypertensionDiabetes+2 more
University of Massachusetts, Worcester68,000 enrolled3 locationsNCT06903897
Recruiting
Not Applicable

WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study

HypertensionType 2 Diabetes Mellitus (T2DM)Prediabetes+3 more
Alexandra Hospital1,700 enrolled1 locationNCT06752772